Robert Burns
Stock Analyst at H.C. Wainwright
(4.80)
# 541
Out of 5,090 analysts
1090
Total ratings
43%
Success rate
18.1%
Average return
Main Sectors:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXEL Exelixis | Reiterated: Buy | $56 → $78 | $69.39 | +12.41% | 26 | Nov 2, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $11 | $1.78 | +517.98% | 43 | Oct 29, 2026 | |
| TNGX Tango Therapeutics | Reiterated: Buy | $68 | $22.72 | +199.30% | 24 | Oct 29, 2026 | |
| AVBP ArriVent BioPharma | Reiterated: Buy | $27 | $14.87 | +81.57% | 21 | Oct 28, 2026 | |
| HURA TuHURA Biosciences | Reiterated: Buy | $10 | $1.93 | +418.13% | 9 | Oct 27, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | $27 | $9.24 | +192.21% | 50 | Oct 27, 2026 | |
| ELTX Elicio Therapeutics | Reiterated: Buy | $23 | $1.68 | +1,269.05% | 17 | Oct 26, 2026 | |
| PBLS Parabilis Medicines | Reiterated: Buy | $40 | $28.32 | +41.24% | 2 | Oct 26, 2026 | |
| ELVN Enliven Therapeutics | Reiterated: Buy | $65 → $73 | $44.25 | +64.97% | 13 | Oct 19, 2026 | |
| NRIX Nurix Therapeutics | Reiterated: Buy | $34 → $36 | $26.80 | +34.33% | 32 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.88 | +106.19% | 26 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.4232 | - | 31 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $15.03 | +132.87% | 14 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $13.75 | +154.55% | 3 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $9.10 | +119.78% | 2 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $34 | $3.42 | +894.15% | 7 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $31.02 | +77.30% | 29 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9 | $0.8896 | +911.69% | 14 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 | $71.78 | +241.32% | 2 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.31 | +281.68% | 23 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $280 | $191.31 | +46.36% | 47 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $55 | $28.61 | +92.24% | 46 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $29 | $18.35 | +58.04% | 36 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $25 | $7.68 | +225.52% | 16 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $4.76 | +341.18% | 34 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $3 | $0.662 | +353.17% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $21 | $2.62 | +701.53% | 8 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.08 | +236.54% | 23 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.58 | +263.13% | 7 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.53 | - | 45 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $1.08 | +1,381.48% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 → $35 | $15.93 | +119.71% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $9.13 | +360.02% | 14 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $1.15 | +1,030.43% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $6.59 | +6.22% | 4 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.40 | - | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $2.62 | +1,006.87% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $88.17 | +47.44% | 104 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.24 | - | 23 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $11 | $1.18 | +832.20% | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $17.61 | - | 44 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.52 | +426.32% | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.01 | n/a | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $20.69 | n/a | 8 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 6 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.32 | n/a | 19 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $20 | $0.688 | n/a | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.28 | n/a | 13 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $27.55 | n/a | 18 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $4.10 | n/a | 7 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.34 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $1.67 | n/a | 16 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.01 | n/a | 8 | Mar 5, 2021 |
Exelixis
Nov 2, 2026
Reiterated: Buy
Price Target: $56 → $78
Current: $69.39
Upside: +12.41%
Black Diamond Therapeutics
Oct 29, 2026
Reiterated: Buy
Price Target: $11
Current: $1.78
Upside: +517.98%
Tango Therapeutics
Oct 29, 2026
Reiterated: Buy
Price Target: $68
Current: $22.72
Upside: +199.30%
ArriVent BioPharma
Oct 28, 2026
Reiterated: Buy
Price Target: $27
Current: $14.87
Upside: +81.57%
TuHURA Biosciences
Oct 27, 2026
Reiterated: Buy
Price Target: $10
Current: $1.93
Upside: +418.13%
ORIC Pharmaceuticals
Oct 27, 2026
Reiterated: Buy
Price Target: $27
Current: $9.24
Upside: +192.21%
Elicio Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $23
Current: $1.68
Upside: +1,269.05%
Parabilis Medicines
Oct 26, 2026
Reiterated: Buy
Price Target: $40
Current: $28.32
Upside: +41.24%
Enliven Therapeutics
Oct 19, 2026
Reiterated: Buy
Price Target: $65 → $73
Current: $44.25
Upside: +64.97%
Nurix Therapeutics
Oct 16, 2026
Reiterated: Buy
Price Target: $34 → $36
Current: $26.80
Upside: +34.33%
Oct 13, 2026
Reiterated: Buy
Price Target: $8
Current: $3.88
Upside: +106.19%
Oct 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.4232
Upside: -
Oct 2, 2026
Reiterated: Buy
Price Target: $35
Current: $15.03
Upside: +132.87%
Sep 30, 2026
Reiterated: Buy
Price Target: $35
Current: $13.75
Upside: +154.55%
Sep 30, 2026
Reiterated: Buy
Price Target: $20
Current: $9.10
Upside: +119.78%
Sep 29, 2026
Reiterated: Buy
Price Target: $27 → $34
Current: $3.42
Upside: +894.15%
Sep 16, 2026
Reiterated: Buy
Price Target: $55
Current: $31.02
Upside: +77.30%
Sep 15, 2026
Upgraded: Buy
Price Target: $9
Current: $0.8896
Upside: +911.69%
Sep 9, 2026
Reiterated: Buy
Price Target: $245
Current: $71.78
Upside: +241.32%
Sep 8, 2026
Reiterated: Buy
Price Target: $5
Current: $1.31
Upside: +281.68%
Aug 27, 2026
Reiterated: Buy
Price Target: $195 → $280
Current: $191.31
Upside: +46.36%
Aug 26, 2026
Reiterated: Buy
Price Target: $51 → $55
Current: $28.61
Upside: +92.24%
Aug 21, 2026
Reiterated: Buy
Price Target: $28 → $29
Current: $18.35
Upside: +58.04%
Aug 10, 2026
Reiterated: Buy
Price Target: $20 → $25
Current: $7.68
Upside: +225.52%
Aug 7, 2026
Reiterated: Buy
Price Target: $21
Current: $4.76
Upside: +341.18%
Jul 31, 2026
Downgraded: Hold
Price Target: $13 → $3
Current: $0.662
Upside: +353.17%
Jul 20, 2026
Reiterated: Buy
Price Target: $27 → $21
Current: $2.62
Upside: +701.53%
Jul 9, 2026
Reiterated: Buy
Price Target: $7
Current: $2.08
Upside: +236.54%
Jul 6, 2026
Reiterated: Buy
Price Target: $13
Current: $3.58
Upside: +263.13%
Jun 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.53
Upside: -
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $1.08
Upside: +1,381.48%
Jun 3, 2026
Rated: Buy
Price Target: $33 → $35
Current: $15.93
Upside: +119.71%
Jun 1, 2026
Reiterated: Buy
Price Target: $42
Current: $9.13
Upside: +360.02%
Jun 1, 2026
Reiterated: Buy
Price Target: $13
Current: $1.15
Upside: +1,030.43%
May 28, 2026
Reiterated: Buy
Price Target: $7
Current: $6.59
Upside: +6.22%
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.40
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: $29
Current: $2.62
Upside: +1,006.87%
Apr 27, 2026
Reiterated: Buy
Price Target: $130
Current: $88.17
Upside: +47.44%
Apr 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.24
Upside: -
Apr 16, 2026
Reiterated: Buy
Price Target: $8 → $11
Current: $1.18
Upside: +832.20%
Apr 13, 2026
Downgraded: Sell
Price Target: n/a
Current: $17.61
Upside: -
Feb 13, 2026
Reiterated: Buy
Price Target: $8
Current: $1.52
Upside: +426.32%
Aug 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.01
Upside: n/a
Sep 3, 2024
Rated: Hold
Price Target: n/a
Current: $20.69
Upside: n/a
Jul 16, 2024
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
May 24, 2024
Rated: Hold
Price Target: n/a
Current: $5.32
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $110 → $20
Current: $0.688
Upside: n/a
Jan 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $3.28
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $27.55
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $22
Current: $4.10
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $11
Current: $2.34
Upside: n/a
Oct 22, 2021
Reiterated: Sell
Price Target: n/a
Current: $1.67
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $10
Current: $1.01
Upside: n/a